In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...
The FDA's cancer advisors will discuss AstraZeneca’s application for the oral SERD camizestrant in breast cancer and the AKT ...
Read more about the under-prescription of first-line treatments for erectile dysfunction in patients with prostate cancer.
MedPage Today on MSN
Bubbles of prostate cancer info; cancer drug tops moneymakers; small kidney tumors
News, features, and commentary about cancer-related issues ...
News-Medical.Net on MSN
Taking anticoagulants alongside prostate cancer drugs does not increase bleeding risk
In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...
The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...
Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...
Bayer sued rival Johnson & Johnson for launching a “false advertising campaign” based on flawed data to wrongfully promote ...
By Puyaan Singh and Sahil Pandey March 6 (Reuters) - The U.S. Food and Drug Administration on Friday approved a new formulation of Lantheus Holdings' prostate cancer imaging agent, aimed at improving ...
The Prostate Cancer Foundation (PCF) today announced the recipients of its 2025 Challenge Awards, providing over $12 million in funding for 12 multi-institutional, cross-disciplinary research teams ...
Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results